Mitral stenosis
Narrowed mitral valve — almost always rheumatic — obstructing LA→LV filling
Overview
Narrowing of the mitral orifice, in the vast majority due to rheumatic heart disease. Obstructed left atrial emptying raises LA pressure → pulmonary congestion, AF and pulmonary hypertension. The signs are a loud S1, an opening snap and a low-pitched mid-diastolic rumble at the apex, with a malar flush.
Recognise
- Exertional dyspnoea, haemoptysis, fatigue; AF (from LA dilatation) with embolic risk; malar flush
- Loud S1, opening snap, and a low-pitched mid-diastolic rumble at the apex (best in the left lateral position)
- Right heart failure and pulmonary hypertension as it progresses
Red flags
- AF with systemic embolism (stroke) — anticoagulate; mitral stenosis AF needs warfarin, not a DOAC, if rheumatic/moderate-severe
- Haemoptysis, severe pulmonary hypertension or right heart failure → urgent valve intervention
Differentials & how to tell them apart
Investigations
Echo (valve area, gradient, LA size, pulmonary pressures — diagnostic); ECG (AF, P mitrale); CXR (LA enlargement, pulmonary congestion); assess for rheumatic mitral/aortic disease.
Management
Rate control + anticoagulation (warfarin) for AF; balloon valvuloplasty or surgery for severe symptomatic MS
- 1Confirm on echo and assess suitability for intervention. Control AF rate and treat congestion with diuretics.Gate: AF in rheumatic/moderate-to-severe mitral stenosis → anticoagulate with WARFARIN, not a DOAC (DOACs are not licensed/effective here).
- 2Severe symptomatic mitral stenosis → percutaneous mitral balloon valvuloplasty if the valve is suitable (no calcification, significant MR or LA thrombus), otherwise surgical replacement/repair.
Key points
Mid-diastolic rumble + opening snap + loud S1 + malar flush, usually rheumatic = mitral stenosis. AF is common and embolic — but in rheumatic/significant MS use WARFARIN not a DOAC. Severe symptomatic disease → balloon valvuloplasty.
Monitor & prognosis
Serial echo, AF/anticoagulation, pulmonary pressures.
Slowly progressive; good after valvuloplasty/replacement; rheumatic disease is declining in the UK.
Source: NICE NG208; ESC valve guideline